|
Market Closed -
BME
16:35:22 25/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 59.15 EUR | -0.59% |
|
+2.60% | -6.85% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 74.36 | +25.71% | 9 | ||||||
| 1,325.39 | +11.99% | 29 | ||||||
| 277.91 | +2.47% | 22 | ||||||
| 278.61 | +5.4% | 28 | ||||||
| 375.34 | +4.17% | 19 | ||||||
| 152.43 | +5.45% | 22 | ||||||
| 211.41 | +27.21% | 23 | ||||||
| 389.22 | -6.12% | 29 | ||||||
| 158.65 | +5.12% | 26 | ||||||
| 307.56 | +21.56% | 23 | ||||||
| 28.88 | +0.72% | 26 | ||||||
| 570.32 | +8.39% | 28 | ||||||
| 66.71 | +6.12% | 24 | ||||||
| 21.75 | +17.49% | 21 | ||||||
| 94.06 | +31.02% | 24 | ||||||
| 9,183.33 | +38.8% | 15 | ||||||
| 6,622.06 | +10.94% | 16 | ||||||
| 58.22 | +16.4% | 18 | ||||||
| 71.35 | +59.06% | 17 | ||||||
| Average | 1,066.71 | +15.36% | 22 | ||||||
| Weighted average by Cap. | 723.37 | +9.74% | 25 |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
